Drug Coated Balloon Is Less Effective for Treatment of DES In-Stent Restenosis Both in Native Coronary Arteries and Saphenous Vein Grafts: Results From a Bicenter Registry
详细信息 查看全文
- 作者：Markus Resch ; Patrick Ostheim ; Dierk H. Endemann ; Kurt Debl ; Stefan Buchner ; Christoph Birner ; Lars S. Maier ; Sebastian Kerber ; Andreas Luchner and Daniel P. Griese
- 刊名：Journal of Interventional Cardiology
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：29
- 期：5
- 页码：461-468
- 全文大小：410K
- ISSN：1540-8183
文摘
The paclitaxel drug coated balloon (DCB) is an established treatment for bare metal stent (BMS) in-stent restenosis (ISR) in native coronary arteries. The evidence of DCB-application for drug eluting stent (DES) ISR both in native coronaries and saphenous vein grafts (SVG) is limited. Aim of our study was to compare the differential efficacy of DCB for treatment of BMS- and DES-ISR in native coronary vessels and SVGs.